Previous close | 1.0300 |
Open | 1.0100 |
Bid | 1.0100 x 400 |
Ask | 1.0700 x 100 |
Day's range | 0.9610 - 1.0499 |
52-week range | 0.7310 - 2.2900 |
Volume | |
Avg. volume | 393,457 |
Market cap | 61.898M |
Beta (5Y monthly) | 1.83 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Kronos Bio (KRON) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Kronos Bio, Inc. (KRON) delivered earnings and revenue surprises of -5.88% and 63.32%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?